References

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

10.3322/caac.21834 · 2024 · External reference

Primary staging with 2[18F]-FDG-PET/CT and -PET/MRI and radiotherapy response evaluation with MRI in uterine cervical cancer: an interim analysis of a prospective clinical trial

10.1186/s41824-024-00236-2 · 2025 · External reference

Evaluation of gynecologic cancer with MR imaging, 18F-FDG PET/CT, and PET/MR imaging

10.2967/jnumed.114.145011 · 2015 · External reference

Correction to: staging, recurrence and follow-up of uterine cervical cancer using MRI: updated guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018

10.1007/s00330-021-08066-7 · 2022 · External reference

Can MRI predict local control rate of uterine cervical cancer immediately after radiation therapy?

10.2463/mrms.9.141 · 2010 · External reference

Interobserver agreement and prognostic impact for MRI-based 2018 FIGO staging parameters in uterine cervical cancer

10.1007/s00330-022-08666-x · 2022 · External reference

10.3390/cancers17050770

10.3390/cancers17050770 · 2025 · External reference

Preoperative tumour size assessment in patients with early-stage cervical cancer: final results of the SENTIX study

10.1016/j.ygyno.2025.04.005 · 2025 · External reference

Response Evaluation Criteria in Solid Tumors (RECIST) and PET Response Criteria in Solid Tumors (PERCIST) for response evaluation of the neck after chemoradiotherapy in head and neck squamous cell carcinoma

10.1002/hed.26583 · 2021 · External reference

Comparative prognostic implication of treatment response assessments in mCRPC: PERCIST 1.0, RECIST 1.1, and PSA response criteria

10.7150/thno.39838 · 2020 · External reference

Comparison of RECIST 1.1, mRECIST and PERCIST for assessment of peptide receptor radionuclide therapy treatment response in metastatic neuroendocrine tumors

10.1067/j.cpradiol.2024.10.003 · 2025 · External reference

Practical PERCIST: a simplified guide to PET Response Criteria in Solid Tumors 1.0

10.1148/radiol.2016142043 · 2016 · External reference

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

10.1016/j.ejca.2008.10.026 · 2009 · External reference

Standards for PET image acquisition and quantitative data analysis

10.2967/jnumed.108.057182 · 2009 · External reference

Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis

10.1016/s1095-0397(99)00016-3 · 1999 · External reference

Understanding the standardized uptake value, its methods, and implications for usage

2004 · External reference

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

10.1007/s00259-014-2961-x · 2015 · External reference

Prognostic value of volume-based metabolic parameters of (18)F-FDG PET/CT in uterine cervical cancer: a systematic review and meta-analysis

10.2214/ajr.18.19734 · 2018 · External reference

Comparison of tumor volumes as determined by pathologic examination and FDG-PET/CT images of non-small-cell lung cancer: a pilot study

10.1016/j.ijrobp.2009.01.019 · 2009 · External reference

Prognostic value of pretreatment FDG PET/CT in uterine cervical cancer according to two major histologic types: squamous cell carcinoma and adenocarcinoma

10.22038/aojnmb.2023.69159.1481 · 2023 · External reference

[(18)F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer

10.1186/s12885-024-12232-7 · 2024 · External reference

Prognostic value of (18)F-FDG PET in uterine cervical cancer patients with stage IIICr allocated by imaging

10.1038/s41598-023-46261-2 · 2023 · External reference

The feasibility of (18)F-FDG PET/CT for predicting pathologic risk status in early-stage uterine cervical squamous cancer

10.1186/s40644-020-00340-z · 2020 · External reference

Exploratory analysis of radiomic as prognostic biomarkers in (18)F-FDG PET/CT scan in uterine cervical cancer

10.3389/fmed.2022.1046551 · 2022 · External reference

Predictive role of post-treatment [18F]FDG PET/CT in patients with uterine cervical cancer

10.1016/j.ejrad.2012.02.015 · 2012 · External reference

Radiologic predictors of disease recurrence in nasopharyngeal carcinoma: a retrospective evaluation of MRI and (18)F-FDG-PET/CT parameters

10.3390/diagnostics15131646 · 2025 · External reference

Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer

10.1016/j.ijrobp.2011.05.053 · 2012 · External reference

Baseline PET features to predict prognosis in primary mediastinal B cell lymphoma: a comparative analysis of different methods for measuring baseline metabolic tumour volume

10.1007/s00259-019-04286-8 · 2019 · External reference

Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma

10.1097/mnm.0000000000000641 · 2017 · External reference

Comparison of the morphologic criteria (RECIST) and metabolic criteria (EORTC and PERCIST) in tumor response assessments: a pooled analysis

10.3904/kjim.2017.063 · 2019 · External reference